AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16936584 — intervention group
Group type: COMPARATOR
Intervention: Partial weightbearing and a conservative training regimen for the first 3 months after surgery
Number of subjects: 29
Study 16563271 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang (0.6 g, Bid)
Number of subjects: 591
Study 12372764 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP + low-calcium diet (approximately 500 mg/day) for 3-6 months in hypercalciuric patients
Number of subjects: 46
Study 12372764 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP for 3-6 months in all patients
Number of subjects: 46
Study 12372764 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet (approximately 500 mg/day) for 3-6 months in hypercalciuric patients
Number of subjects: 46
Study 12372764 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP for 3-6 months in normocalciuric children
Number of subjects: 46
Study 10197860 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra)
Number of subjects: 111
Study 10197860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 10197860 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (age-matched healthy subjects)
Number of subjects: 111
Study 8849179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin 400 mg
Number of subjects: 120
Study 8849179 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin 250 mg
Number of subjects: 120
Study 1431364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (CFPM) 1.0 g twice daily for 14 days
Number of subjects: 183
Study 1431364 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (CAZ) 1.0 g twice daily for 14 days
Number of subjects: 183
Study 4005394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalexin 500 mg
Number of subjects: 12
Study 4005394 — intervention group
Group type: COMPARATOR
Intervention: Cefadroxil 500 mg
Number of subjects: 12
Study 31100296 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of perceived exertion-based high-intensity cycling exercise
Number of subjects: 32
Study 31100296 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 32
Study 29851567 — intervention group
Group type: EXPERIMENTAL
Intervention: Elder mistreatment
Number of subjects: 400
Study 29851567 — intervention group
Group type: EXPERIMENTAL
Intervention: Family environment with psychological and physical abuse
Number of subjects: 400
Study 29851567 — intervention group
Group type: EXPERIMENTAL
Intervention: Social environment characterized by loneliness
Number of subjects: 400
Study 29851567 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistreated older adults
Number of subjects: 400
Study 27142231 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritually framed breast cancer screening message
Number of subjects: 200
Study 27142231 — intervention group
Group type: COMPARATOR
Intervention: Traditional breast cancer screening message
Number of subjects: 200
Study 24803174 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of phonics, reading comprehension strategies, and reading speed
Number of subjects: 112
Study 21755578 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (three walks)
Number of subjects: 30
Study 21755578 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (two walks)
Number of subjects: 30
Study 21755578 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (one walk)
Number of subjects: 30
Study 21755578 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 30
Study 20921836 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type-A (BTX-A) injection
Number of subjects: 27
Study 20921836 — intervention group
Group type: COMPARATOR
Intervention: Control drug (NaCl 0.9% or bupivacaine 0.25%)
Number of subjects: 27
Study 18522664 — intervention group
Group type: EXPERIMENTAL
Intervention: QI-Meds
Number of subjects: 805
Study 18522664 — intervention group
Group type: EXPERIMENTAL
Intervention: QI-Therapy
Number of subjects: 805
Study 18522664 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 805
Study 16083067 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose MNZ (2 g daily for 7 days)
Number of subjects: 30
Study 16083067 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg N‐9 vaginal suppository daily for 7 days
Number of subjects: 30
Study 16083067 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional MNZ dose (1 g daily for 7 days) plus 100 mg N‐9 suppository for 7 days
Number of subjects: 30
Study 11840225 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg once daily
Number of subjects: 61
Study 11840225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 9597063 — intervention group
Group type: EXPERIMENTAL
Intervention: CL-CANE
Number of subjects: 24
Study 9597063 — intervention group
Group type: EXPERIMENTAL
Intervention: CL-CANE+
Number of subjects: 24
Study 9597063 — intervention group
Group type: COMPARATOR
Intervention: IL-CANE
Number of subjects: 24
Study 9316695 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA (LD) treatment
Number of subjects: 0
Study 9316695 — intervention group
Group type: COMPARATOR
Intervention: Unmedicated state
Number of subjects: 0
Study 3354990 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (25 mg four times a day for 7 doses)
Number of subjects: 7
Study 3354990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 30844990 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (AR)
Number of subjects: 25
Study 30844990 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (PR)
Number of subjects: 25
Study 29327644 — intervention group
Group type: EXPERIMENTAL
Intervention: PREHAB+ (once weekly supervised prehabilitation)
Number of subjects: 80
Study 29327644 — intervention group
Group type: COMPARATOR
Intervention: REHAB (standard rehabilitation)
Number of subjects: 80
Study 27064347 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Psychotherapy/Dance Movement Therapy (BPT/DMT) - 20 sessions
Number of subjects: 68
Study 27064347 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 68
Study 24300949 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Self-efficacy (MSE) training
Number of subjects: 153
Study 24300949 — intervention group
Group type: COMPARATOR
Intervention: Peer support group
Number of subjects: 153
Study 22938573 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm implants
Number of subjects: 95
Study 22938573 — intervention group
Group type: COMPARATOR
Intervention: 11 mm implants
Number of subjects: 95
Study 22938573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study 20413999 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 139
Study 20413999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 20031783 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) plus optimal medical therapy
Number of subjects: 2287
Study 20031783 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 2287
Study 20031783 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2287
Study 16341846 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (open-label for 12 weeks)
Number of subjects: 29
Study 16341846 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (double-blind phase)
Number of subjects: 29
Study 16341846 — intervention group
Group type: COMPARATOR
Intervention: Placebo (double-blind phase)
Number of subjects: 29
Study 14604881 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic examination training
Number of subjects: 72
Study 14604881 — intervention group
Group type: COMPARATOR
Intervention: Educational literature (Control)
Number of subjects: 72
Study 10944126 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2 plus oxaliplatin (200 mg/m2/d leucovorin, 400 mg/m2/d bolus 5FU, 600 mg/m2/d infusional 5FU for 2 days every 2 weeks, plus 85 mg/m2 oxaliplatin on day 1)
Number of subjects: 420
Study 10944126 — intervention group
Group type: COMPARATOR
Intervention: LV5FU2 alone (200 mg/m2/d leucovorin, 400 mg/m2/d bolus 5FU, 600 mg/m2/d infusional 5FU for 2 days every 2 weeks)
Number of subjects: 420
Study 10944126 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2 plus oxaliplatin
Number of subjects: 420
Study 10944126 — intervention group
Group type: COMPARATOR
Intervention: LV5FU2 alone
Number of subjects: 420
Study 8746336 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcitriol (1.5 micrograms per day, 15 micrograms/g of Vaseline)
Number of subjects: 84
Study 8746336 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcitriol ointment (15 micrograms/g Vaseline) applied to all lesions (up to 10 g, 150 micrograms calcitriol)
Number of subjects: 84
Study 8746336 — intervention group
Group type: COMPARATOR
Intervention: Vaseline (placebo)
Number of subjects: 84
Study 8227844 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cycle length of 400 ms with up to at least four extrastimuli
Number of subjects: 28
Study 8227844 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cycle length of 600 ms
Number of subjects: 28
Study 8227844 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus rhythm
Number of subjects: 28
Study 8227844 — intervention group
Group type: COMPARATOR
Intervention: Basic cycle lengths of 400 ms and 600 ms
Number of subjects: 28
Study 8227844 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cycle length of 400 ms
Number of subjects: 28
Study 3512021 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled environment unit
Number of subjects: 60
Study 3512021 — intervention group
Group type: COMPARATOR
Intervention: Plaster dressings
Number of subjects: 60
Study 29975091 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective state of mind
Number of subjects: 0
Study 29975091 — intervention group
Group type: COMPARATOR
Intervention: Objective state of mind
Number of subjects: 0
Study 29975091 — intervention group
Group type: COMPARATOR
Intervention: Laboratory experiment (objective state)
Number of subjects: 0
Study 27206539 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR‐BI
Number of subjects: 1567
Study 27206539 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no IVR‐BI)
Number of subjects: 1567
Study 25037455 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience-based intervention in intervention schools
Number of subjects: 32
Study 25037455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 22019502 — intervention group
Group type: EXPERIMENTAL
Intervention: Athlete-modified dissonance prevention
Number of subjects: 157
Study 22019502 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy weight intervention (AM-HWI)
Number of subjects: 157
Study 22019502 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 157
Study 20510549 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin Assisted Treatment (HAT)
Number of subjects: 251
Study 20510549 — intervention group
Group type: COMPARATOR
Intervention: Optimized Methadone Maintenance Treatment (MMT)
Number of subjects: 251
Study 18677239 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% Carbomer 934
Number of subjects: 65
Study 18677239 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18% sodium hyaluronate (SH)
Number of subjects: 65
Study 16685988 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple electrophysiological atlases used for DBS target point prediction
Number of subjects: 0
Study 16685988 — intervention group
Group type: COMPARATOR
Intervention: Single reference volume (not explicitly mentioned but implied as a comparison)
Number of subjects: 0
Study 12765436 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-animation programs (candles and balloon)
Number of subjects: 88
Study 12765436 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with a program for a short period of time before the formal lung-function test
Number of subjects: 88
Study 10337847 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse counseling
Number of subjects: 77
Study 10337847 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 77
Study 8543957 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 0
Study 8543957 — intervention group
Group type: EXPERIMENTAL
Intervention: Manufacturer and brand of L-tryptophan
Number of subjects: 0
Study 8543957 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 1791086 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose verapamil (120 mg)
Number of subjects: 10
Study 1791086 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven-doses of verapamil (120 mg thrice daily)
Number of subjects: 10
Study 6780258 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) treatment for 48 hours
Number of subjects: 46
Study 30872114 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-in questionnaire/live telephone interviews
Number of subjects: 0
Study 30872114 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone/interactive voice recognition
Number of subjects: 0
Study 30872114 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based computer Kiosk technologies
Number of subjects: 0
Study 30872114 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home instruments
Number of subjects: 0
Study 27873477 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedically supported case management
Number of subjects: 46
Study 27873477 — intervention group
Group type: COMPARATOR
Intervention: Standard aftercare
Number of subjects: 46
Study 25623343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBT-I), 8 sessions
Number of subjects: 100
Study 25623343 — intervention group
Group type: COMPARATOR
Intervention: Behavioral desensitization (active placebo)
Number of subjects: 100
Study 25623343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBT-I)
Number of subjects: 100
Study 24140142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection
Number of subjects: 101
Study 24140142 — intervention group
Group type: COMPARATOR
Intervention: Periarticular injection
Number of subjects: 101
Study 22171804 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management programme (n = 80)
Number of subjects: 160
Study 22171804 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (n = 80)
Number of subjects: 160
Study 18323556 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 44
Study 18323556 — intervention group
Group type: COMPARATOR
Intervention: PEG interferon alpha-2b
Number of subjects: 44
Study 16685556 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Hardinge approach with limited incision (average 10 cm)
Number of subjects: 0
Study 16685556 — intervention group
Group type: COMPARATOR
Intervention: Standard incision (not directly compared in this study)
Number of subjects: 0
Study 12582402 — intervention group
Group type: EXPERIMENTAL
Intervention: Denileukin diftitox
Number of subjects: 1
Study 10783015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (60 mg of retinol as retinyl palmitate) during acute diarrhea
Number of subjects: 68
Study 10783015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (60 mg of retinol as retinyl palmitate) after resolution of diarrhea
Number of subjects: 68
Study 10783015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation during acute diarrhea
Number of subjects: 68
Study 10783015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation after resolution of diarrhea
Number of subjects: 68
Study 10783015 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A supplementation (both during acute diarrhea and after resolution)
Number of subjects: 68
Study 8803503 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (2 g, administered 2 hours before and after 20 km of the marathon)
Number of subjects: 7
Study 8803503 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 7
Study 1615614 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (20 mg/m2 body surface area)
Number of subjects: 111
Study 1615614 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 111
Study 6235140 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg twice daily
Number of subjects: 93
Study 6235140 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 1 g/wk intramuscularly
Number of subjects: 93
Study 6235140 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (TAM and MPA)
Number of subjects: 93
Study 31810057 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - heel drop exercises for 13 weeks including 1 week of control, 8 weeks of eccentric training, and 4 weeks of detraining.
Number of subjects: 45
Study 31810057 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no muscular training.
Number of subjects: 45
Study 29580754 — intervention group
Group type: COMPARATOR
Intervention: SIT + PA
Number of subjects: 36
Study 29580754 — intervention group
Group type: COMPARATOR
Intervention: RAB
Number of subjects: 36
Study 29580754 — intervention group
Group type: COMPARATOR
Intervention: RAB + PA
Number of subjects: 36
Study 28214943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh fixation group (n = 50)
Number of subjects: 100
Study 28214943 — intervention group
Group type: COMPARATOR
Intervention: Mesh non-fixation group (n = 50)
Number of subjects: 100
Study 28214943 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 26292721 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 52
Study 26292721 — intervention group
Group type: COMPARATOR
Intervention: Blinded continuous glucose monitoring
Number of subjects: 52
Study 23323964 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable mandibular retractor (RMR)
Number of subjects: 67
Study 21663656 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Residual Spraying (IRS with DDT)
Number of subjects: 1000
Study 21663656 — intervention group
Group type: COMPARATOR
Intervention: Long-Lasting Insecticidal Nets (LLINs)
Number of subjects: 1000
Study 18962989 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA 2 g/day
Number of subjects: 84
Study 18962989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 16622734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (severe, moderate, mild)
Number of subjects: 1210
Study 16622734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (severe, moderate)
Number of subjects: 1210
Study 16622734 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual biochemical parameters (calcium, phosphate, Alk Ph)
Number of subjects: 1210
Study 14507300 — intervention group
Group type: EXPERIMENTAL
Intervention: Female elite athletes
Number of subjects: 1440
Study 14507300 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 1440
Study 14507300 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletes with eating disorders (ED)
Number of subjects: 1440
Study 14507300 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ED athletes
Number of subjects: 1440
Study 14507300 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletes
Number of subjects: 1440
Study 10990101 — intervention group
Group type: EXPERIMENTAL
Intervention: Stericath closed suctioning system (S+, n = 54)
Number of subjects: 104
Study 10990101 — intervention group
Group type: COMPARATOR
Intervention: Routine management (S-, n = 50)
Number of subjects: 104
Study 8737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 8737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0
Study 8737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0
Study 8737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 0
Study 8737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 1555559 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 40 W
Number of subjects: 6
Study 1555559 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 80 W
Number of subjects: 6
Study 1555559 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 120 W
Number of subjects: 6
Study 1555559 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 160 W
Number of subjects: 6
Study 1555559 — intervention group
Group type: COMPARATOR
Intervention: Rest after exercise
Number of subjects: 6
Study 4054194 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 143
Study 4054194 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.d. (twice daily)
Number of subjects: 143
Study 4054194 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily
Number of subjects: 143
Study 4054194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 29565695 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy with complete macular internal limiting membrane peeling
Number of subjects: 0
Study 29565695 — intervention group
Group type: COMPARATOR
Intervention: Preservation of the epi‐foveal membrane
Number of subjects: 0
Study 30135541 — intervention group
Group type: EXPERIMENTAL
Intervention: Iterative model reconstruction (IMR) with 80 kV/30 ml contrast media
Number of subjects: 83
Study 30135541 — intervention group
Group type: COMPARATOR
Intervention: Filtered back projection (FBP) with 100 kV/50 ml contrast media
Number of subjects: 83
Study 26457466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 169
Study 26457466 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 169
Study 26457466 — intervention group
Group type: EXPERIMENTAL
Intervention: HAMSIQ
Number of subjects: 169
Study 25363127 — intervention group
Group type: EXPERIMENTAL
Intervention: triamcinolone 0.5 mL with lidocaine 2%
Number of subjects: 48